Cargando…
Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the Western world, and it’s likely to parallel the increasing prevalence of type 2 diabetes, obesity, and other components of metabolic syndrome. However, optimal treatment for NAFLD has...
Autores principales: | Mengesha, Tewodros, Sekaran, N. Gnana, Mehare, Tsegaye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011178/ https://www.ncbi.nlm.nih.gov/pubmed/33785007 http://dx.doi.org/10.1186/s12906-021-03275-5 |
Ejemplares similares
-
Correction to: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
por: Mengesha, Tewodros, et al.
Publicado: (2021) -
Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats
por: Mukhtar, Shanza, et al.
Publicado: (2021) -
Fructose-Drinking Water Induced Nonalcoholic Fatty Liver Disease and Ultrastructural Alteration of Hepatocyte Mitochondria in Male Wistar Rat
por: Mamikutty, Norshalizah, et al.
Publicado: (2015) -
Olanzapine-induced hepatopathy in albino rats: A newer model for screening putative hepatoprotective agents, namely silymarin
por: Sengupta, Parama, et al.
Publicado: (2010) -
Antioxidant Actions of Thymoquinone, Silymarin, and Curcumin on
Experimental Aortic Ischemia-Reperfusion Model in Wistar Albino
Rats
por: Yardımcı, Mustafa, et al.
Publicado: (2022)